Diaphragmatic Palsy Due to a Paraneoplastic Autoimmune Syndrome Revealed by Checkpoint Inhibitors by Jean-Baptiste Destival, Jean-Marie Michot, Cécile Cauquil, Nicolas Noël, Salima Hacein-Bey-Abina, Pascale Chrétien, Olivier Lambotte

Subjects: Get full text

Immunotherapy in Non-Small-Cell Lung Cancer: A Modified Delphi Survey Consensus on First Line Treatment, Special Populations and Rechallenge by Francesca Colonese, Alessandra Bulotta, Carlo Genova, Diego Signorelli, Laura Bonanno, Claudia Proto, Immunotherapy in NSCLC Delphi Panel, Diego Luigi Cortinovis

Subjects: Get full text

Potential predictive biomarkers in antitumor immunotherapy: navigating the future of antitumor treatment and immune checkpoint inhibitor efficacy by Xiangyu Yin, Xiangyu Yin, Xiangyu Yin, Xiangyu Yin, Yunjie Song, Wanglong Deng, Neil Blake, Xinghong Luo, Jia Meng, Jia Meng, Jia Meng

Subjects: Get full text

Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trial... by Andrea Messori, Andrea Ossato, Lorenzo Gasperoni, Luna Del Bono, Alessandro Inno, Vera Damuzzo

Subjects: “…immune checkpoint inhibitors…”
Get full text

Establishment of an animal model of immune‐related adverse events induced by immune checkpoint inhibitors by Yuan Meng, Yingge Lv, Meng Shen, Wenwen Yu, Yumeng Liu, Ting Liu, Gen Liu, Shiya Ma, Zhenzhen Hui, Xiubao Ren, Liang Liu

Subjects: Get full text

Neoadjuvant chemoradiotherapy up-regulates PD-L1 in radioresistant colorectal cancer by Sung Uk Bae, Hye Won Lee, Jee Young Park, Incheol Seo, Jae-Min Cho, Jin Young Kim, Ju Yup Lee, Yoo Jin Lee, Seong Kyu Baek, Nam Kyu Kim, Sang Jun Byun, Shin Kim

Subjects: Get full text

Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes by Jiexi Yan, Lu Yang, Qingmiao Ren, Chan Zhu, Haiyun Du, Zhouyu Wang, Yaya Qi, Xiaohong Xian, Dongsheng Chen

Subjects: “…immune-checkpoint inhibitors…”
Get full text

Clinical Characteristics and Outcomes of TFE3-Rearranged/TFEB-Altered Renal Cell Carcinoma with Systemic Therapies, Including Tyrosine Kinase Inhibitors or Immune Checkpoint Inhibi... by Joohyun Hong, Ghee Young Kwon, Minyong Kang, Seong Il Seo, Se Hoon Park

Subjects: Get full text

Immune-checkpoint-inhibitor therapy directed against PD-L1 is tolerated in the heart without manifestation of cardiac inflammation in a preclinical reversible melanoma mouse model by Caroline Schoenherr, Caroline Schoenherr, Stefan Pietzsch, Stefan Pietzsch, Cristina Barca, Franziska E. Müller, Frauke S. Bahr, Martina Kasten, Andre Zeug, Sergej Erschow, Christine S. Falk, Evgeni Ponimaskin, James T. Thackeray, Denise Hilfiker-Kleiner, Denise Hilfiker-Kleiner, Melanie Ricke-Hoch

Subjects: “…immune checkpoint inhibitors…”
Get full text

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab by Meng Wu, Claudia A.M. Fulgenzi, Antonio D’Alessio, Alessio Cortellini, Ciro Celsa, Giulia F. Manfredi, Bernardo Stefanini, Y. Linda Wu, Yi-Hsiang Huang, Anwaar Saeed, Angelo Pirozzi, Tiziana Pressiani, Lorenza Rimassa, Martin Schoenlein, Kornelius Schulze, Johann von Felden, Yehia Mohamed, Ahmed O. Kaseb, Arndt Vogel, Natascha Roehlen, Marianna Silletta, Naoshi Nishida, Masatoshi Kudo, Caterina Vivaldi, Lorenz Balcar, Bernhard Scheiner, Matthias Pinter, Amit G. Singal, Joshua Glover, Susanna Ulahannan, Fredrich Foerster, Arndt Weinmann, Peter R. Galle, Neehar D. Parikh, Wei-Fan Hsu, Alessandro Parisi, Hong Jae Chon, David J. Pinato, Celina Ang

Subjects: Get full text

A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma by Daniel S. Alicea, MS, Bijal Amin, MD, Beth N. McLellan, MD

Subjects: “…immune-checkpoint inhibitors…”
Get full text

Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives by Yuhang Chen, Suoyi Dai, Chien-shan Cheng, Lianyu Chen

Subjects: Get full text

Adjuvant and neoadjuvant immunotherapy for acral and mucosal melanoma by Takaya Komori, Shigeru Koizumi, Sadao Inoue, Maiko Yamaura, Yuri Murayama, Atsushi Otsuka, Yasuhiro Nakamura

Subjects: Get full text

Current Status and Research Progress of Immunotherapy for Colorectal Cancer by Xiangchen ZHANG, Xinjun LIANG, Shaozhong WEI

Subjects: Get full text

Effects of combined radiotherapy with immune checkpoint blockade on immunological memory in luminal-like subtype murine bladder cancer model by JiaMin Huang, Eva Michaud, Surashri Shinde-Jadhav, Sabina Fehric, Gautier Marcq, Jose Joao Mansure, Fabio Cury, Fadi Brimo, Ciriaco A. Piccirillo, Wassim Kassouf

Subjects: Get full text

Clinical characteristics of patients requiring emergency hospitalization due to immune-related adverse events: a retrospective study by Tatsuki Ikeda, Satoru Nihei, Kazuki Saito, Junichi Asaka, Kenzo Kudo

Subjects: “…Immune checkpoint inhibitors…”
Get full text

Discontinuation of immune checkpoint inhibitors for reasons other than disease progression and the impact on relapse and survival of advanced melanoma patients. A systematic review... by Konstantinos Lallas, Eftychia Chatziioannou, Derya Durak, Georg Frey, Lina Maria Serna-Higuita, Marie-Lena Rasch, Athanassios Kyrgidis, Eleni Timotheadou, Zoe Apalla, Ulrike Leiter, Lukas Flatz, Lukas Flatz, Aimilios Lallas, Teresa Amaral, Teresa Amaral

Subjects: Get full text

Pan‐Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System by Sean R. Miller, Matthew Schipper, Lars G. Fritsche, Ralph Jiang, Garth Strohbehn, Erkin Ötleş, Benjamin H. McMahon, Silvia Crivelli, Rafael Zamora‐Resendiz, Nithya Ramnath, Shinjae Yoo, Xin Dai, Kamya Sankar, Donna M. Edwards, Steven G. Allen, Michael D. Green, Alex K. Bryant

Subjects: Get full text

Comparative efficacy of programmed death ligand 1 inhibition and chemotherapy in advanced gastric or gastroesophageal junction cancer with combined positive score – a meta-analysis... by Zakari Shaibu, Fumeng Yang, Liu Ting, Lily Dzidula, Amina Elmi Yusuf, Zhi-hong Chen, Wei Zhu

Subjects: Get full text

Deep learning of pretreatment multiphase CT images for predicting response to lenvatinib and immune checkpoint inhibitors in unresectable hepatocellular carcinoma by Nan-Qing Liao, Zhu-Jian Deng, Wei Wei, Jia-Hui Lu, Min-Jun Li, Liang Ma, Qing-Feng Chen, Jian-Hong Zhong

Subjects: Get full text